Biotech Showcase
Join us virtually
January 10–12, 2022 &January 17–19, 2022

Marian Nakada
VP, Venture Investments at Johnson & Johnson Innovation, JJDC

Profile

Marian Nakada Ph.D., VP Venture Investments for Johnson & Johnson Innovation – JJDC, has almost 30 years of experience in the pharmaceutical industry, starting her career at the laboratory bench at Centocor and moving to a research leadership role before Centocor’s acquisition by Johnson & Johnson in 1999. She transitioned to Janssen Business Development where she executed deals to support the expansion of the Biologics portfolio. She joined JJDC, Johnson & Johnson’s corporate venture group in 2013. She is passionate about leveraging Johnson & Johnson’s capabilities to help her portfolio companies succeed. Marian has a B.A. in Biology from Harvard College and a Ph.D. in Pharmacology from the University of Pennsylvania. She is currently on the Boards of Navitor Pharmaceuticals, Twenty-eight Seven Therapeutics, Ribon Therapeutics, Artizan Biosciences as well as the New England Venture Capital Association where she is working to champion change as an active contributor to its Diversity & Inclusion Committee.


Agenda Sessions

  • Early Seed Financing: What are the Best Funding Strategies for Biotech Start-ups?

    10:00